Focus:
Cardiovascular
-
4 December 2019 News
Impulse Dynamics raises funds towards Optimizer Smart System
Impulse Dynamics, developer of Optimizer Smart System for delivering CCM therapy, has raised $80.25m through Series D financing round, which had seen the participation of several new investors.
-
3 December 2019 Comment
LivaNova abandons transcatheter mitral valve replacement device market
LivaNova recently announced its decision to discontinue investments into its Caisson Interventional transcatheter mitral valve replacement (TMVR) programme. The decision to end the programme enables the company to focus on...
-
3 December 2019 News
Study finds proteins from single blood test help predict disease risks
A team of researchers from the University of California, Cambridge University and SomaLogic have found that the large-scale measurement of proteins from a single blood test could effectively predict people's...
-
27 November 2019 News
Indian stent-maker SMT acquires majority stake in Zarek
Indian medical devices firm Sahajanand Medical Technologies (SMT) has acquired a majority stake in Brazil-based medical devices solution provider Zarek Distribuidora De Produtos Hospitalares for an undisclosed amount.
-
22 November 2019 News
Nightingale Health opens private placement round
Finland-based blood testing technology provider Nightingale Health has opened a private placement round of €50m-€80m as part of its strategy to take its preventative health technology to international markets.
-
21 November 2019 projects
Barostim Neo Neuromodulation System
Barostim Neo® is a neuromodulation system developed by CVRx for the treatment of heart failure and hypertension. The system received CE mark from the National Standards Authority of Ireland (NSAI)...
-
21 November 2019 News
LivaNova to revamp heart valve division to affect 150 jobs
UK-based medical technology firm LivaNova has decided to overhaul its heart valve division to address the continued decline in sales.
-
20 November 2019 News
USFDA grants Breakthrough Device Designation for BioVentrix’s Revivent TC system
BioVentrix, a US-based a privately-held medical device company, has secured Breakthrough Device Designation status from the US Food and Drug Administration (FDA) for its Revivent TC Transcatheter Ventricular Enhancement System...
-
19 November 2019 News
Impella heart pumps associated with complications after stent procedure
Impella heart pumps have been associated with serious complications in critically ill patients who require a pump to support circulation as part of stent procedures.
-
19 November 2019 News
Biofourmis signs agreement to acquire Biovotion
US-based digital therapeutics company Biofourmis has signed an agreement to acquire Switzerland-based Biovotion, a developer of a clinical-grade wearable biosensor platform.